Aprogen Biologics Inc. Logo

Aprogen Biologics Inc.

Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.

003060 | KO

Overview

Corporate Details

ISIN(s):
KR7003060001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩), 서울특별시

Description

Aprogen Biologics Inc. is a biopharmaceutical company focused on the development and manufacturing of antibody-based therapeutics. The company's activities encompass two main areas: the creation of novel biologics and the production of biosimilars. Its pipeline of new drugs includes candidates for treating conditions such as blood vessel diseases and tumors. Simultaneously, Aprogen develops a portfolio of biosimilar products to offer alternatives to existing biologic medicines. The company operates significant manufacturing facilities to support the production of its biopharmaceutical products for both clinical trials and commercial supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean 100.6 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 5.0 MB
2025-08-01 00:00
주식등의대량보유상황보고서(일반)
Korean 102.1 KB
2025-05-30 00:00
기업지배구조보고서공시
Korean 639.1 KB
2025-05-26 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 67.8 KB
2025-05-26 00:00
타법인주식및출자증권취득결정
Korean 17.7 KB
2025-05-22 00:00
타법인주식및출자증권처분결정
Korean 16.0 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 3.2 MB
2025-05-07 00:00
[기재정정]임원ㆍ주요주주특정증권등거래계획보고서
Korean 73.8 KB
2025-05-07 00:00
주식등의대량보유상황보고서(일반)
Korean 103.2 KB
2025-05-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-04-25 00:00
주식등의대량보유상황보고서(일반)
Korean 94.2 KB
2025-04-25 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-04-25 00:00
주권관련사채권의처분결정
Korean 16.4 KB
2025-04-11 00:00
타인에대한담보제공결정
Korean 15.7 KB

Automate Your Workflow. Get a real-time feed of all Aprogen Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aprogen Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aprogen Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.